⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVTX News
Avalo Therapeutics, Inc. Common Stock
Asthma - Pipeline Insight, 2026 | 100+ Pipeline Drugs Drive Growth in Long-Acting Biologics and Strategic Licensing Opportunities
globenewswire.com
AZN
AMGN
PFE
CLDX
AVTX
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AVTX
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress
globenewswire.com
AVTX
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AVTX
Avalo Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
AVTX
Global Cancer Peptide Drug Market Report 2026: Opportunities, Approved Drug Dosage, Price, Sales & Clinical Trials Insights to 2031
globenewswire.com
LLY
NVS
AVTX
Form 8-K
sec.gov
AVTX
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
globenewswire.com
AVTX
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
globenewswire.com
AVTX
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
globenewswire.com
AVTX